News Sprint Bioscience AB

Equities

SPRINT

SE0006343745

Delayed Nasdaq Stockholm Other stock markets 08:05:31 2024-05-22 EDT			5-day change	1st Jan Change
1.272 ^SEK	-8.49%		-4.65%	-26.69%

05-08	Sprint Bioscience AB Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
02-14	Sprint Bioscience AB Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Sprint Bioscience - Improved sales and activity	05-10	AQ
Sprint Bioscience AB Reports Earnings Results for the First Quarter Ended March 31, 2024	05-08	CI
Positive preclinical results in Sprint Bioscience's oncology program targeting TREX1	04-11	AQ
New data from the VPS34 program published	03-20	AQ
Sprint Bioscience participates in a delegation trip to Washington DC	03-08	AQ
Sprint Bioscience Q4 2023 - A major step towards break-even	02-15	AQ
Sprint Bioscience AB Reports Earnings Results for the Full Year Ended December 31, 2023	02-14	CI
Sprint Bioscience AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	02-14	CI
Sprint Bioscience’s DISA program further validated in two recent scientific publications	01-22	AQ
Sprint Bioscience - Replacing Decipher as a VPS34 partner	01-02	AQ
Sprint Bioscience - Easing pressure and a sharper focus on value drivers	11-20	AQ
Sprint Bioscience AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	23-10-25	CI
Sprint Bioscience - New beginnings	23-09-13	AQ
Sprint Bioscience AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-24	CI
Sprint Bioscience licenses the VADA (VRK1) program to Day One Biopharmaceuticals	23-08-16	AQ
Sprint Bioscience Licenses the Vada Program to Day One Biopharmaceuticals	23-08-16	CI
Sprint Bioscience Q1 2023 - VADA deal needed	23-05-11	AQ
Sprint Bioscience AB Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-10	CI
Sprint Bioscience presents preclinical data from the DISA program at research conference	23-05-02	AQ
Sprint Bioscience Q4 2022 - Temporary setbacks	23-02-16	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Sprint Bioscience AB

Equities

SPRINT

SE0006343745

Summary

Filters